Welcome to LookChem.com Sign In|Join Free

CAS

  • or

144655-81-2

Post Buying Request

144655-81-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

144655-81-2 Usage

General Description

4-(2-Oxoimidazolidin-1-yl)benzonitrile is a chemical compound with the molecular formula C12H10N4O. It is a white powder with a molecular weight of 214.24 g/mol. 4-(2-Oxoimidazolidin-1-yl)benzonitrile is used in the synthesis of various pharmaceutical and chemical products. It is known for its ability to act as an intermediate in the production of anti-cancer and antiviral drugs. Additionally, it has applications in organic synthesis and is utilized as a reagent in laboratory research. However, due to its potential toxicity and hazardous nature, it should be handled and stored with care, following proper safety protocols.

Check Digit Verification of cas no

The CAS Registry Mumber 144655-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,6,5 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 144655-81:
(8*1)+(7*4)+(6*4)+(5*6)+(4*5)+(3*5)+(2*8)+(1*1)=142
142 % 10 = 2
So 144655-81-2 is a valid CAS Registry Number.

144655-81-2Relevant articles and documents

IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS

-

Page/Page column 81-82, (2019/10/15)

The present invention relates to the derivatives of compound of formula (I) and pharmaceutically acceptable salts thereof. The present invention further provides the methods of preparation of compound of formula (I) and use thereof as PRMT5 inhibitors. Th

Platelet aggregation inhibitors

-

, (2008/06/13)

This invention relates to compounds having the following formula STR1 or a pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 144655-81-2